ReviewThe international journal of cardiovascular imaging2025
Reimagining chronic total occlusion management interventions: the role of artificial intelligence in imaging, planning, and procedural guidance.
Review in The international journal of cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic Total Occlusions (CTOs) remain among the most complex lesions encountered in percutaneous coronary intervention (PCI), presenting significant technical and clinical challenges due to ambiguous vessel anatomy, lesion heterogeneity, and high operator variability. Although recent advancements in interventional techniques have improved success rates, procedural outcomes remain variable. The integration of Artificial Intelligence (AI) into CTO management offers the potential to optimize each stage of care, including lesion assessment, procedural planning, real-time intra-procedural support, and post-procedural outcome prediction. This review synthesizes current evidence on AI applications across the CTO care continuum, highlighting the role of deep learning in imaging modalities such as optical coherence tomography (OCT) and coronary computed tomography angiography (CCTA), as well as machine learning models such as XGBoost for procedural strategy and outcome forecasting. Commercial platforms including Ultreon OCT and HeartFlow FFRCT demonstrate early translational value, although validation in CTO-specific contexts remains limited. Ethical considerations such as algorithmic transparency, data generalizability, and clinician trust are also addressed, with attention to explainable AI methods such as SHAP and LIME. As AI technologies continue to advance, future research should prioritize the development of interpretable, clinically validated models and encourage multidisciplinary collaboration to support ethical integration into interventional cardiology and improve patient outcomes.
Indexed as
Identifiers
41105294What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.